Literature DB >> 7252155

Growth of 17D yellow fever virus in a macrophage-like cell line, U937: role of Fc and viral receptors in antibody-mediated infection.

J J Schlesinger, M W Brandriss.   

Abstract

Growth characteristics of 17D yellow fever virus (17D-YF) and conditions for infection were studied in U937, a macrophage-like, Fc receptor-bearing continuous human cell line. Antibody to 17D-YF was obtained by immunization of normal subjects with 17D-YF vaccine. Cells were infected in the presence or absence of immune whole sera or immunoglobulin fractions. Infection of U937 was temperature dependent; the yield of virus was variable but at low temperature viral titers were consistently higher when infection was established in the presence of antibody. Results of infectious center assays indicated that the increased yield of virus was largely or entirely due to an increase in the number of cells producing virus early in the course of infection. Enhancement of viral growth was mediated by IgG but not IgM fractions of immune sera. Trypsinization of U937 resulted in a 90 to 95% reduction of infection in the absence of antibody but in the presence of antibody viral titers were higher in trypsinized than in nontrypsinized cells. Antibody to 17D-YF, contained in the whole IgG fraction of sera, bound to U937 to mediate infection without first being complexed to virus. Preincubation of U937 with IgG1 but not IgG2 myeloma proteins abrogated antibody-mediated infection. This result is compatible with the known affinities of U937 Fc receptors for specific subclasses of IgG and provides evidence for the role of the Fc receptor in antibody-mediated enhancement of viral growth. Persistent infection characterized by a lack of detectable cytopathogenic effect was established in long-term cultures of U937. This pattern of infection might be related to the unique effectiveness of the 17D-YF vaccine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7252155

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1.

Authors:  H Ochiai; M Kurokawa; K Hayashi; S Niwayama
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Increase of retroviral infection in vitro by the binding of antiretroviral antibodies.

Authors:  P Legrain; B Goud; G Buttin
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

3.  Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants.

Authors:  W E Brandt; J M McCown; M K Gentry; P K Russell
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

Review 4.  Fc receptor--more answers, more questions.

Authors:  L Fornůsek; V Vĕtvicka
Journal:  Folia Microbiol (Praha)       Date:  1984       Impact factor: 2.099

5.  Immunological enhancement and the pathogenesis of dengue haemorrhagic fever.

Authors:  J S Porterfield
Journal:  J Hyg (Lond)       Date:  1982-12

6.  Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus.

Authors:  E Rieder; A Berinstein; B Baxt; A Kang; P W Mason
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

Review 7.  Fc gamma receptors in cancer and infectious disease.

Authors:  M W Fanger; D V Erbe
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

8.  Role of antibodies and host cells in plaque enhancement of Murray Valley encephalitis virus.

Authors:  S C Kliks; S B Halstead
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

9.  RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.

Authors:  P W Mason; E Rieder; B Baxt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

10.  Replication of virulent and attenuated strains of yellow fever virus in human monocytes and macrophage-like cells (U937).

Authors:  F Liprandi; R Walder
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.